Clinical Trials Logo

Esophageal Cancers NOS clinical trials

View clinical trials related to Esophageal Cancers NOS.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03416244 Completed - Esophageal Cancer Clinical Trials

A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer

RAMONA
Start date: February 21, 2018
Phase: Phase 2
Study type: Interventional

Cancer - including esophageal squamous cell cancer (ESCC) - is a disease of the elderly but little is known about the biology and progression of cancers in these patients. While most patients receive chemotherapy and/or chemo-radiation as first treatment, no treatment standard for following treatments has been established so far and there is a clear unmet medical need, especially for elderly patients. Hence, this study assesses the efficacy and safety of two experimental immunotherapy regimens (Nivolumab monotherapy or Nivolumab/Ipilimumab combination) in elderly patients with advanced esophageal squamous cell cancer.